Further support for the role for AKT signaling in intrinsic BRAF inhibitor resistance came from other studies showing that overexpression of an active form of AKT3 (myristolated AKT3) prevented apoptosis in BRAF V600E mutant melanoma cells when BRAF was inhibited [49]. This evidence concerns the gene AKT1 and melanoma.